Citigroup’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $575K | Sell |
|
|||||
|
2025
Q2 | $657K | Sell |
|
|||||
|
2025
Q1 | $2.16M | Buy |
|
|||||
|
2024
Q4 | $2.64M | Buy |
|
|||||
|
2024
Q3 | $3.24M | Buy |
|
|||||
|
2024
Q2 | $2.03M | Sell |
|
|||||
|
2024
Q1 | $5.69M | Buy |
|
|||||
|
2023
Q4 | $2.29M | Sell |
|
|||||
|
2023
Q3 | $1.95M | Buy |
|
|||||
|
2023
Q2 | $2.69M | Sell |
|
|||||
|
2023
Q1 | $4.07M | Buy |
|
|||||
|
2022
Q4 | $2.06M | Sell |
|
|||||
|
2022
Q3 | $3.77M | Buy |
|
|||||
|
2022
Q2 | $2.71M | Buy |
|
|||||
|
2022
Q1 | $2.69M | Sell |
|
|||||
|
2021
Q4 | $5.92M | Buy |
|
|||||
|
2021
Q3 | $4.28M | Sell |
|
|||||
|
2021
Q2 | $6.21M | Buy |
|
|||||
|
2021
Q1 | $4.3M | Buy |
|
|||||
|
2020
Q4 | $932K | Buy |
|
|||||
|
2020
Q3 | $393K | Sell |
|
|||||
|
2020
Q2 | $1.71M | Buy |
|
|||||
|
2020
Q1 | $1.82M | Buy |
|
|||||
|
2019
Q4 | $1.53M | Sell |
|
|||||
|
2019
Q3 | $3.71M | Buy |
|
|||||
|
2019
Q2 | $2.22M | Sell |
|
|||||
|
2019
Q1 | $2.73M | Sell |
|
|||||
|
2018
Q4 | $6.58M | Buy |
|
|||||
|
2018
Q3 | $694K | Buy |
|
|||||
|
2018
Q2 | $258K | Buy |
|
|||||
|
2018
Q1 | $189K | Sell |
|
|||||
|
2017
Q4 | $4.08M | Buy |
|
|||||
|
2017
Q3 | $3.59M | Sell |
|
|||||
|
2017
Q2 | $4.2M | Buy |
|
|||||
|
2017
Q1 | $2.6M | Sell |
|
|||||
|
2016
Q4 | $6.43M | Buy |
|
|||||
|
2016
Q3 | $456K | Buy |
|
|||||
|
2016
Q2 | $505K | Sell |
|
|||||
|
2016
Q1 | $2.46M | Buy |
|
|||||
|
2015
Q4 | $607K | Sell |
|
|||||
|
2015
Q3 | $1.01M | Buy |
|
|||||
|
2015
Q2 | $664K | Buy |
|
|||||
|
2015
Q1 | $583K | Sell |
|
|||||
|
2014
Q4 | $1.03M | Buy |
|
|||||
|
2014
Q3 | $565K | Buy |
|
|||||
|
2014
Q2 | $352K | Sell |
|
|||||
|
2014
Q1 | $320K | Buy |
|
|||||
|
2013
Q4 | $167K | Sell |
|
|||||
|
2013
Q3 | $422K | Buy |
|
|||||
|
2013
Q2 | $52K | Buy |
|